Management of intracranial meningioma: Outcome analysis and clinico radiological profile of 172 patients
Authors:
- Aditya VarshneyAVAditya Varshney
- Somil JaiswalSJSomil Jaiswal
- Ankur BajajABAnkur Bajaj
- Awdhesh YadavAYAwdhesh Yadav
- Chhitij SrivastavaCSChhitij Srivastava
- Anil ChandraACAnil Chandra
- Bal Krishna OjhaBOBal Krishna Ojha
- Shalini BhallaSBShalini Bhalla
- Pooja JaiswalPJPooja Jaiswal
- Brijesh Pratap SinghBSBrijesh Pratap Singh
- Manish Kumar SinghMSManish Kumar Singh
Open Access
- 13 December 2024
- journal article
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 15, 464
Abstract
Background: Meningioma is the most common primary intracranial tumor. This single-center study aimed to analyze the clinicopathological, radiological profile, and outcomes of patients with intracranial meningiomas in terms of functional status, morbidity, mortality, and recurrence-free survival (RFS). Methods: Patients of intracranial meningioma treated between January 01, 2010, and December 31, 2019, at the Department of Neurosurgery, King George’s Medical University, India, were included in this study. Retrospective data analysis of 172 patients with intracranial meningioma was done. Results: The majority of the patients, that is, 94 (54.65%), presented in the 4th and 5th decade. The mean size of the meningioma was 36.4 ± 4 mm (range: 26–68 mm). Of the 172 patients, 128 (74.41%) were diagnosed as non-skull base meningiomas, and in 44 patients (25.59%), meningioma originated from the skull base. Recurrence was observed on follow-up imaging in 11 patients after a mean postoperative interval of 55.2 ± 5.8 months. Radiological meningioma recurrence paralleled with clinical deterioration in seven patients. Three of these patients were subjected to the second surgery, followed by radiotherapy, and in the remaining four patients, Gamma knife or fractionated radiotherapy was given. Conclusion: The majority of patients had good functional outcomes (KPS >70) at discharge. Morbidity and mortality was 18.60% and 3.49%, respectively. Meningioma size ≥4 cm, age >45 years, World Health Organization Grade (II, III), non-skull base location, and Simpson grade III, IV of resection showed significantly shorter RFS.Keywords
This publication has 33 references indexed in Scilit:
- Incidence, mortality and outcome of meningiomas: A population-based study from GermanyCancer Epidemiology, 2019
- Neurosurgical treatment and outcome patterns of meningioma in Sweden: a nationwide registry-based studyActa Neurochirurgica, 2019
- Factors Associated with Recurrence of Intracranial Meningiomas After Surgical Resection: A Retrospective Single-Center StudyInternational Journal of Gerontology, 2018
- The Simpson grading in meningioma surgery: does the tumor location influence the prognostic value?Journal of Neuro-Oncology, 2017
- Intracranial meningioma surgery in the elderly (over 65 years): prognostic factors and outcomeActa Neurochirurgica, 2015
- Epidemiology and etiology of meningiomaJournal of Neuro-Oncology, 2010
- Pathologic significance of the “dural tail sign”European Journal of Radiology, 2009
- MeningiomaCritical Reviews in Oncology/Hematology, 2008
- Intracranial meningiomas: Analysis of recurrence after surgical treatmentActa Neurochirurgica, 1994
- Recurrences in meningioma after surgeryActa Neurochirurgica, 1989